Amarantus BioScience Holdings, Inc. is a publicly traded biotechnology company focused on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology.
110 Wall Street
New York, NY 10005 US
Biological Product Manufacturing (except Diagnostic) (325414)
Biological Products, Except Diagnostic (2836)